How genomic information is accessed in clinical practice: an electronic survey of UK general practitioners by R. H. Evans, William et al.
ORIGINAL ARTICLE
How genomic information is accessed in clinical practice:
an electronic survey of UK general practitioners
W. R. H. Evans1 & J. Tranter1 & I. Rafi2 & J. Hayward3 & N. Qureshi1
Received: 23 October 2019 /Accepted: 13 February 2020
# The Author(s) 2020
Abstract
Genomic technologies are having an increasing impact across medicine, including primary care. To enable their wider adoption
and realize their potential, education of primary health-care practitioners will be required. To enable the development of such
resources, understanding where GPs currently access genomic information is needed. One-hundred fifty-nine UKGPs completed
the survey in response to an open invitation, between September 2017 and September 2018. Questions were in response to 4
clinical genomic scenarios, with further questions exploring resources used for rare disease patients, direct-to-consumer genetic
testing and collecting a family history. Respondents were most commonly GP principals (independent GPs who own their clinic)
(64.8%), aged 35–49 years (54%), worked as a GP for more than 15 years (44%) and practiced within suburban locations
(typically wealthier) (50.3%). The most popular ‘just in time’ education source for all clinical genomic scenarios were online
primary care focussed resources with general Internet search engines also popular. For genomic continuous medical education,
over 70% of respondents preferred online learning. Considering specific scenarios, local guidelines were a popular resource for
the familial breast cancer scenario. A large proportion (41%) had not heard of Genomics England’s 100,000 genome project. Few
respondents (4%) would access rare disease specific Internet resources (Orphanet, OMIM). Twenty-five percent of respondents
were unsure how to respond to a direct-to-consumer commercial genetic test query, with 41% forwarding such queries to local
genetic services. GPs require concise, relevant, primary care focussed resources in trusted and familiar online repositories of
information. Inadequate genetic education of GPs could increase burden on local genetic services.
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Abbreviations
CKS The National Institute for
Health and Care Excellence Clinical
Knowledge Summaries
CME Continuing medical education
DOH Department of Health
DTC Direct-to-consumer
EPR Electronic patient record
FH Familial hypercholesterolaemia
FBC Familial breast cancer
GP General practitioner
HEE Health Education England
NICE The National Institute for
Health and Care Excellence
RCGP The Royal College of General Practitioners
Introduction
Genomics is the study of the whole genome and how it works.
Its range of applications is increasing, and currently it plays a
role in the diagnosis, prevention and treatment of rare
inherited diseases, cancers and infectious diseases. As geno-
mic applications continue to broaden, knowledge of its
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application will be required in all areas of medicine including
primary care (Talwar et al. 2016).
Patients with genetic diseases are common in general prac-
tice. Rare diseases, for example, 80% of which have a genetic
basis (Institute of Medicine Committee on Accelerating Rare
Diseases Research and Orphan Product 2010), may be indi-
vidually rare but are collectively common with an estimated
prevalence of 3.5–5.9% (Nguengang Wakap et al. 2019).
General practitioners play a pivotal role in identifying,
supporting and managing patients and their families with
inherited disorders, and as the largest group of clinicians
working in the NHS, with 54,024 licenced GPs in England
and Scotland in 2016 (GMC 2018), will be expected to play a
greater role in frontline genetic and genomic services.
There are a wide range of genomic educational and infor-
mation resources available but little evidence of the applica-
bility and educational effectiveness of these resources for pri-
mary health-care practitioners (Talwar et al. 2016). Genomic
knowledge is limited across medical specialties including pri-
mary care, with practitioners often lacking confidence when
communicating this information to patients (Talwar et al.
2016; Burke et al. 2006); there is concern that limited knowl-
edge and skills may lead to genomic tests either not being used
or misused with consequential harm to patients (Crellin et al.
2019; Burton et al. 2017). Nonetheless, primary care providers
perceive genetics as being important (Mikat-Stevens et al.
2014) and have expressed a willingness to enhance their
knowledge of genetics (Qureshi et al. 2002).
To ensure resources are appropriate and optimized for GPs,
it is important to understand how and where practitioners cur-
rently access information around genomics, particularly with-
in the consultation. It is known that GPs access genetic infor-
mation when they perceive it to be relevant, when they are
presented with a clinical problem, rather than proactively ‘just
in case’ they come across such a scenario (Mikat-Stevens et al.
2014; Mathers et al. 2010). However, currently little is known
about which information is accessed during a consultation.
To identify current and potential educational approaches
and sources of genomic information, an electronic survey
based on 4 short clinical scenarios was distributed to GPs
across the UK. The findings could then be used to provide a
platform of information to develop suitable and targeted re-
sources for GPs to manage genomic scenarios in clinical
practice.
The objective was firstly to capture which educational ap-
proaches are currently used for genomic clinical scenarios:
& Internet resources – including specific web pages
& Intranet resources – local guidelines, resources embedded
in the electronic patient record such as referral templates
or care pathways
& Local specialist for further information via referral or tele-
phone advice
And secondly to develop a greater understanding of the
resources utilized for certain specific genomic scenarios:
& Resources to support clinicians looking after rare disease
patient
& Direct-to-consumer genetic testing
& Collecting a family history
Further information was captured on GP’s preferences re-
garding the format and length of time devoted to genomic
education.
Methods
Study design and study sample
The electronic survey was designed by a steering group of
practising GPs and academics at the University of
Nottingham following a structured review of the literature.
Previous studies identified the utility of using a scenario-
based survey (Hapgood et al. 2002; Qureshi et al. 2002,
2006). Following review by 4 GP colleagues for face validity,
the survey was uploaded and shared on the online survey
platform JISC (Jisc 2019). A link to the electronic survey
was distributed to practising GPs across the UK via a range
of methods: an electronic link in the monthly RCGP e-
newsletter; local GP information circulars and GP support
pages on social media platforms such as Facebook and
Twitter. The survey included an introductory page describing
the background to the survey and ethics information for par-
ticipants. The survey was open for 1 year from September
2017 to September 2018.
Survey questionnaire
GPs were asked what sources they would access for 4 clinical
scenarios:
1. A 41-year-old man with possible familial hypercholester-
olaemia (FH).
2. A 32-year-old woman concerned about familial breast
cancer (FBC).
3. A 28-year-old lady attending for preconception advice, as
her sister has a child with Batten disease. Batten disease,
also known as CLN3, is a rare fatal inherited degenerative
neurological disorder of childhood (Mole and Williams
2001 Oct 10 [Updated 2013 Aug 1]).
4. A patient wishing to discuss a direct-to-consumer genetic
test report.
Suggested responses for sources of information included
Internet resources such as Clinical Knowledge Summaries
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(CKS), an online open access evidence base summary main-
tained by the National Institute for Health and Care
Excellence (NICE 2019), and GP notebook, an online refer-
ence resource across a wide range of clinical areas targeted for
primary care clinicians (General Practice Notebook 2019).
Other resources included information held on the intranet, a
local closed network with resources often embedded in or
linked from the clinical software. This includes local path-
ways; information held within referral templates; mentor a
clinical library linked from the electronic patient record sys-
tem (EPR) and PRODIGY clinical guidelines and protocols
linked from the EPR. In addition, there was the option to liaise
with or refer to primary or secondary care colleagues. The
survey requested responders to choose all that applied as well
giving an option ‘other’ for free text responses.
The survey also asked GPs:
& Their view on genomic educational resources, both the
format and length of time they would be willing to spend
on keeping up to date
& How they currently approach recording a family history
Data analysis
Descriptive statistics were used to assess the proportion of
responses for questions based on each of the 4 clinical
scenarios.
Demographic data gathered included information on par-
ticipants’ job profile, age, the length of time they had been a
GP, practice list size, as a measure of workload, and practice
setting (urban/suburban/rural) with suburban practices typi-
cally having a wealthier patient population.
Results
A total of 159 surveys were received. The majority of respon-
dents were GP principals, independent GPs who own their
clinics (64.8%), aged 35–49 years (54%), worked as a GP
for more than 15 years (44%), practised within a suburban
location (50.3%) and worked in a practice with a list size less
than 10,000 (49%) (Table 1).
Respondents were asked how they had accessed the sur-
vey: most respondents had received a link from a colleague
(47%); however, some had accessed the survey link via social
media platforms (Facebook (24%) and Twitter (2%)). Other
methods of accessing the online survey link were stated as the
RCGP newsletter (12%), local CCG newsletter (7%) and local
research network (8%).
Care pathways/local guidelines
Care pathways and local guidelines, often available on local
intranet systems, were a more frequently preferred resource
for the familial breast cancer (FBC) scenario than the familial
hypercholesterolaemia (FH) scenario. It was rarely considered
a resource for the Batten disease (BD) scenario. Of these in-
tranet resources, local guidelines were the most popular re-
source for both FBC (69%) and FH (50%) (Table 2).
Table 1 Characteristics
of respondents n (%)
Personal characteristics
Age in years
< 35 years 20 (12.6)
35–49 years 86 (54.1)
> 49 years 53 (33.3)
Job profile
GP principal 103 (64.8)
Salaried GP 34 (21.4)
Locum 16 (10.1)
GP in training 5 (3.1)
Other 1 (10.6)
Practice location
Rural 19 (11.9)
Suburban 80 (50.3)
Inner city 60 (37.7)
Practice list size
< 10,000 75 (49)
10,000–12,000 21 (13.7)
12,000–14,000 23 (15)
14,000–16,000 18 (11.8)
> 16,000 16 (10.5)
Length of time as GP
< 5 years 27 (16)
5–10 years 37 (23)
10–15 years 25 (15)
> 15 years 70 (44)
Table 2 Respondents preferred intranet options for genomic
information when presented with a patient with a genomic disorder
(Multi-answer: respondents were asked to mark all that applied)
Disease FH FBC BD
Intranet resource n (%) n (%) n (%)
Templates 30 (19) 60 (38) 0
Care pathways 43 (27) 78 (49) 0
Local trust guidelines 79 (50) 109 (69) 1 (0.6)
Mentor/prodigy 44 (28) 1 (0.6) 1 (0.6)
Local CCG update 18 (11) 0 0
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Internet searches and resources
NICE Clinical Knowledge Summary (CKS) were a popular
resource for both FH (67%) and the FBC (68%) scenarios
(Table 3). GP notebook was also frequently chosen as a re-
source in the FH (64%), FBC (68%) and in response to a
follow on question in the FBC scenario, when a specific can-
cer predisposition gene mutation is found in a close relative
(see question 15 Appendix 1) (53%).
Respondents in all scenarios used Internet search engines
(e.g. Google/Bing), with 48% of respondents choosing it for
the DTC genetic testing and FBC scenarios. Thirty-eight per-
cent of respondents chose Internet search engines for the FH
scenario.
A substantial proportion of GPs had not heard of the
100,000 genome project (65/159 (41%)). The majority of
GPs would use search engines (Google/Bing) to access more
information on this project (91%), with far fewer accessing
information directly from a Department for Health or govern-
ment web page (19%).
Local advice support
Local guidelines are an important resource for the two more
common genetic disorders and of these highlighted more fre-
quently for the FBC scenario than the FH scenario (Table 2).
Local clinical genetic services or other specialists (e.g. lipid
clinics) remain an important source of information in all sce-
narios. Similarly, the follow on question in the FBC scenario,
(question 15 Appendix 1) where a specific cancer
predisposition gene mutation is found in a close relative gen-
erated a wide range of responses. The most commonly select-
ed responses involved seeking advice from secondary care
colleagues (68%).
Genomic continuing medical education
When asked how GPs would like to keep up to date with
genomic medicine, online educational modules were the most
popular (70% of GPs expressed an interest in this method);
educational materials embedded in the clinical systems (52%)
or educational content given in the referral templates (49%)
were also popular. When asked how long they would wish to
spend on an online learning module 78% of GPs selected
either 30 min or 1 h.
Forty-two percent of respondents expressed interest in at-
tending a teaching session by their local CCG, and when
asked how long they would wish to attend most (72%) felt
that 1–3 h would be sufficient. There was a preference for
evening meetings (38%), with a lunchtime update chosen as
the second most popular choice (22%).
A proportion of respondents would not attend a continuing
medical education (CME) session on genomic medicine
(17%). Comments were received on the unrealistic demands
on CME across the breadth of medicine. Further comments
highlighted the need for ‘just in time’ resources that are well
placed, easy to find and from trusted providers. Further com-
ments expressed frustration that there are simply too many
resources available, meaning it can be hard to navigate and
find the best quality resources, with a further comment
Table 3 Respondents preferred
Internet options for genomic
information when presented with
patient with a genomic disorder
(Multi-answer: respondents were
asked to mark all that applied)
Internet resource FH FBC Batten disease
n (%) n (%) n (%)
GP notebook 103 (64) 106 (67) 102 (64)
CKS 107 (67) 108 (68) 56 (35)
Online educational modules
(RCGP, Doctor.net, HEE, BMJ online)
46 (30) 0 0
Google/Bing 60 (38) 76 (48) Not asked
NICE guidance 12 (4) 74 (47) 0
SIGN 2 (1) 0 0
Online text book 0 12 (8) 31 (12)
Youtube 0 11 (7) 0
Social media (Facebook, WhatsApp) 2 (1) 29 (18) 0
DOH website 0 0 0
Disease-specific online resource 3 (2) (*SB) 0 80 (50) (BDFA)
General online rare disease resource 0 58 (36) 12 (4)
Red whale 2 (1) 1 (0.6) 0
Wikipedia 0 0 1 (0.6)
Online journal search 0 0 1 (0.6)
*SB (Simon Broome criteria) BDFA (Batten Disease Family Association)
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requesting ‘access to online, up to date, concise clinical infor-
mation as and when we need it’.
Rare disease resources
Intranet resources were not identified as a helpful for the
Batten disease scenario (Table 2).
Internet resources were widely used in this scenario with
GP notebook identified as the most popular Internet resource
(64%) and disease-specific online information such as the
Batten disease foundation’s web page (50%) also popular.
CKS was less useful than other scenarios (35%) (Table 3).
Very few (4%) consider using general rare disease online re-
sources such as Orphanet or OMIM; however, a large number
of free text responses simply stated ‘Google’ for information
(Chart 1).
Direct communication or referral to local specialist or ge-
netic service was overwhelmingly the most popular response
when deciding on the next step to explore preconception test-
ing (Chart 2).
Commercial direct-to-consumer genetic testing
The survey asked GPs, to pick one resource they would access
to gain further information on the value of commercial direct-
to-consumer (DTC) genetic testing, most (48%) would use an
Internet search engine. Forty-one percent of responses said
they would either contact or refer to a local specialist.
A subsequent question asked to pick a single option that
would help to support them in reassuring a patient anxious
following a DTC test that indicates an increased risk of
dementia.
Twenty-three percent of respondents indicated they were
unsure, and 30% either indicated a referral to genetics or a
letter from a specialist. Statements from organizations such
as RCGP (14%) or the Department of Health (14%) were also
popular (Chart 3).
Collecting a family history and managing a patient
with a family history of cancer
The vast majority of GPs indicated that they had asked a
patient to collect a family history (90%). When asked how
they request patients to do this, the most popular options were
to ask patients to write a list of relatives (47%), utilize a tem-
plate from a local genetic clinic (38%) or draw a family tree
(31%). (Table 4).
Discussion
Principal findings
GPs surveyed want Internet-based ‘just in time’ resources
found in trusted and familiar places, such as GP primary care
online educational resources (GP notebook) and national
Chart 1 Where GPs would look
for information about Batten
disease during a consultation
(Multi-answer: respondents were
asked to mark all that applied)
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evidence-based resources (NICE Clinical Knowledge
Summary (CKS)).
Local specialists and the genetic service remain an impor-
tant resource for advice and guidance.
Referral pathways and local guidelines, through intranet
access, were identified as valuable resources for the FH and
FBC scenarios. The popularity of this approach with the FBC
scenario may indicate respondents’ knowledge of existing lo-
cal guidance for FBC and/or familiarity with referral pathways
for cancers in general.
The rare disease scenario showed that commonly used
Internet resources, GP notebook and CKS are popular places
to access information. Additionally disease-specific informa-
tion such as rare disease charity web pages was also highlight-
ed. Ensuring the accuracy and relevance of information for
rare diseases in these widely accessed sites should be ensured.
Interestingly, internationally commissioned resources for rare
diseases, Orphanet and OMIM, were not used, perhaps a re-
flection of a general lack of awareness. This echoes the find-
ings in a survey of Belgian family practitioners (Vandeborne
et al. 2019). Although the question posed did not have a
specific option for search engines (Google/ Bing), free text
responses suggest that this is a popular option. Ensuring that
appropriate and accurate resources come out at the top of these
searches should also be prioritized.
There were mix of responses to the direct-to-consumer ge-
netic testing scenario, with Internet search engines (Google/
Bing) as the most popular choice. Such searches were gener-
ally more popular when the question posed was less clearly
defined or associated with greater uncertainty in how it should
be dealt with. Even still, 41% of GPs highlighted that they
would either refer or liaise with their local specialist or genetic
service. In the context of an increase in the uptake of such
testing, this may pose a challenge for genetic services. The
most recent data from 23andme suggests that 1.9% of people
with reports will attend their GP to discuss the findings, pre-
viously estimated at 4% in 2015. If 41% of these consultations
lead to a contact with genetic services, this will generate 1500
additional referrals or requests for advice (23andme 2019).
Greater guidance on how one should approach such scenarios
should be made available to primary care to ensure the appro-
priate use of clinical genetic services (Horton et al. 2019).
Chart 3 Which further resource would you consider to be the most helpful to support you regarding the value of this commercial genetic testing result
and allay patient anxiety? (Single response question)
Chart 2 Where GPs access
information about a patient’s risk
of having a child with Batten
disease? (Multi-answer
respondent were asked to mark all
that applied)
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Somewhat surprisingly, given its degree of publicity, a sub-
stantial proportion of GPs had not heard of the 100,000 ge-
nome project (41%). The majority of GPs would use search
engines (Google/Bing) to access more information on this
project (91%), with only a relatively small number accessing
directly a Department of Health or government web page for
more information (19%).
Writing a list of relatives was the most popular method to
collect a family history and is a recognized approach to collate
this information (Valdez et al. 2010; Qureshi et al. 2009) Also
local templates were utilized by some. The mix of approaches
amongst respondents may reflect the lack of a single suitable
resource or a general lack of awareness of such a resource.
Suitable, codable and searchable methods of collecting the
details of a family history that is embedded in the electronic
patient record system would be of great value.
Previous research
This study is the first to ask about the current practice of UK
GPs regarding genomic scenarios and to explore their attitude
and approach to emerging genomic advances.
The preparedness of clinicians to practice genomic med-
icine has been highlighted to be dependent upon several
factors: confidence, perception of the utility of the test,
experience, education and the resources available to
support them (Paul et al. 2018; Crellin et al. 2019).
Previous studies had shown that UK primary care clini-
cians lack confidence in dealing with clinical genetic sce-
narios with low levels of genetic training reported in sur-
veys of non-genetic specialists (Burke et al. 2006; Qureshi
et al. 2002). Studies have explored the genetic educational
needs and preferred approaches in primary care. Calefato
et al. (2008) highlighted the genetic educational priorities
in primary care physicians in five European countries. A
survey of UK GPs has previously demonstrated they val-
ued educational resources that focus on their needs: the
recognition and referral of patients and the specific actions
they need to take (Burke et al. 2006). Similar priorities
were shown in a study of GP’s in the Netherlands with
the additional priority: ‘Knowledge of the possibilities
and limitations of genetic tests’ (Houwink et al. 2012).
The need to improve genomic education is increasingly
acknowledged across the range of specialities with its in-
corporation into undergraduate and postgraduate curricula
and the development of genetic ‘clinical champions’ to
develop genomics in their own specialty (Slade and
Burton 2016). Mainstream genetic testing is increasingly
common in specialties such as oncology, cardiology and
paediatrics. How one approaches this is said to be a bal-
ance between the push of information from the genetic
community, which has frequently been met with resis-
tance by many specialities who could not see the rele-
vance or found it hard to incorporate this into their work
streams and the pull for knowledge from physicians when
this genomic information has been shown to be relevant
and have clinical utility for their patients (Feero and
Green 2011).
Our survey demonstrated a preference for online geno-
mic education. Qureshi et al. (2002) highlighted a prefer-
ence for face-to-face meetings for genetic education, and
other educational approaches were offered as options but
not specifically online resources. This preference for face-
to-face educational meetings has been shown across a
range of CME topics; however, in a subset of younger
clinicians, online educational materials were more popular
with a frequently expressed benefit of ‘anytime and any-
place’ ease of use. Interestingly Braithwaite et al. (2002),
in a study aimed at assessing attitudes to a decision support
tool for familial cancer, concluded that GPs prefer Internet
resources for medical education, as it is both quick and
inexpensive. Our finding suggests that for ‘just in time’
genomic information, there is a shift in clinician preference
towards online resources available in or between consulta-
tions, echoing findings of other studies (Houwink et al.
2012). This is perhaps as one would expect as clinicians’
knowledge and experience of online learning have in-
creased in the years since the earlier studies of GP’s
preference.
Table 4 Respondents preferred options for recording and managing a
family history of cancer (Multi-answer respondent were asked to mark all
that applied)
Resource n (%)
Write a list of relatives 74 (47)
Draw a family tree 49 (31)
Template from local genetic clinic 60 (38)
Complete regional genetics family history form 1 (0.6)
Oxford Cancer genetics referral form 2 (13)
FAHRAS software 1 (0.6)
Internet resources
Downloadable online tool 9 (6)
Google/Bing 41 (26)
Clinical Knowledge Summaries 108 (68)
GP notebook 91 (57)
Online educational module
i.e. RCGP, HEE, Doctor.net 58 (36)
Online textbook 12 (8)
Youtube 11 (7)
Intranet resources
Template 59 (37)
Local guidelines 109 (69)
Care pathways 78 (49)
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Vandeborne et al. (2019) surveyed Belgian GP’s rare
disease educational needs. They highlighted the following
areas: prevention and screening, patient referral, differen-
tial diagnoses and rare disease symptoms. Furthermore,
their focus group suggested an up-to-date digital plat-
form, freely available in the physicians’ language of
choice and validated by numerous rare disease specialists
and experts as the most useful resource (Vandeborne
et al. 2019). Similarly in a UK survey of the information
needs of UK GPs looking after patients with a rare dis-
ease, osteogenesis imperfecta, they suggested web-based
resources linked to the EPR as the optimum platform
(Zack et al. 2006).
Strengths and limitations
The approach of comparing modalities of information and
education across 4 scenarios, each carefully prepared to reflect
situations GPs are routinely exposed to, is a strength of this
study. It enables the identification of key themes and differ-
ences across a range of genomic presentations.
A weakness is the generalizability of the sample. A large
proportion of responses were at the request of a colleague;
consequently, there was geographical clustering, most notably
in West Yorkshire where two authors (WE and JH) are based.
This area uniquely has a GPwSI in genetics (JH) which may
partly explain a proportion of respondents choosing ‘liaising
with a primary care colleague’ for the scenarios: gaining in-
formation about the 100,000 genome project and managing
patients with breast cancer gene mutations in close relatives.
This may not be reflected nationally.
As the study was by open invitation, we could not identify
the denominator population; hence, we are unable to calculate
response rate. However, the survey was shared nationally
through different methods, so a total of 159 responses suggest
the response rate was low. This raises further questions about
the generalizability of this sample; does the wider population
have less interest/knowledge of genomics?
Key findings for clinical applications
This survey indicates the need for well-placed, concise,
online, ‘just in time’ genomic information and educational
resources targeted for GPs. These findings are highly rel-
evant as mainstreaming of genomics is implemented.
Pathways should ensure opportunities are utilized and
maximized for disseminating information, for example,
the design of test reports, the linking of laboratory results
directly to pathways and resources held in places that GPs
are familiar with and accessible options for seeking spe-
cialist guidance (Hayward et al. 2017). To ensure this
occurs, there must be clear links between the clinical im-
plementation of genomic testing and the provision of
educational resources and pathways for GPs (Crellin
et al. 2019). Efforts to optimize the design of test reports
for non-specialists (Recchia et al. 2019) give a further
opportunity for ‘just in time’ education.
It is already acknowledged that the increasing demand
for genetic testing exceeds the capacity of clinical genet-
ics departments (Slade and Burton 2016). This study
highlights potential further demands with primary care
sending additional queries and referrals. In all scenarios,
local genetic services were a popular source of informa-
tion, including inherited cancer predispositions and DTC
genetic test queries. Is there capacity within the regional
genetic service for this demand? Will new models of
working need to be developed to meet this demand and
realize the potential of genomic medicine?
Genomics England has a bold ambition to mainstream ge-
nomics. The fact that 41% of GPs surveyed had not heard of
their flagship 100,000 genome project does makes one ques-
tion, the success of their approach to ensuring the NHS work-
force is on board with this goal.
Suggested further research
One area of further research, highlighted by the relatively
few survey responses and the significant number of GPs
unaware of the 100,000 genome project, is an exploration
of the relevance of genomics to primary care and the
barriers to engagement. The concept of ‘just in time’ re-
sources popular in this survey suggests that the best way
to engage the workforce is at the moment of its relevance.
Would an appropriate initial step be to share genetic test
results, appropriately designed for that audience, with the
clinical genetics or other specialty letter to develop a
workforce that is both increasingly aware of its relevance
and literate in genomics?
Certainly for this survey, further resources could enable its
extension to capture a greater number and spread of the pri-
mary care workforce. Themes identified in this survey could
be explored in greater detail through focus groups or one-to-
one interviews, as well as additional genomic scenarios such
as dealing with the uncertainty generated by tests results such
as variants of uncertain significance or genes with reduced
penetrance.
Engagement with secondary care and genomic services for
advice remains a popular resource. How this should be done is
less clear with a range of responses. Exploring the optimum
methods of working and communication would be a further
research area of value.
Any educational resources and interventions developed as
a result of these study findings should be evaluated for their
effectiveness following a robust and structured appraisal pro-
cess ((EPOC) 2015).
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